RitalinMeSH concept

https://www.has-sante.fr/jcms/p_3305318/fr/ritaline-lp-methylphenidate-tdah
2021
false
false
false
France
evaluation of the transparency committee
methylphenidate
indicators
lipoprotein(a)
indicators and reagents
attention deficit disorder with hyperactivity
traction
methylphenidate
Ritalin
indication of

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61810983
2013
summary of product characteristics
methylphenidate hydrochloride
capsules
Ritalin
methylphenidate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64348400
2012
France
summary of product characteristics
package leaflet
capsules
Ritalin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68808796
2012
France
summary of product characteristics
package leaflet
capsules
Ritalin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69348361
2012
France
summary of product characteristics
package leaflet
capsules
Ritalin

---
http://www.reseau-pic.info/?dest=medicaments/ritaline_enfant.htm&med=RITALINE®
2007
France
drug information
methylphenidate
Ritalin
child

---
http://www.has-sante.fr/portail/display.jsp?id=c_399583
2002
France
evaluation of the transparency committee
Ritalin
tablets

---
https://www.inspq.qc.ca/toxicologie-clinique/ritalinr-pour-ou-contre
1996
false
false
false
Canada
journal article
Ritalin

---